ASR Vermogensbeheer’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
29,139
+3,331
+13% +$1.24M 0.12% 177
2026
Q1
$7.56M Buy
25,808
+441
+2% +$145K 0.09% 200
2025
Q4
$8.89M Sell
25,367
-220
-0.9% -$74.3K 0.1% 182
2025
Q3
$8.27M Sell
25,587
-101
-0.4% -$31.4K 0.1% 179
2025
Q2
$9.99M Sell
25,688
-198
-0.8% -$79.6K 0.13% 153
2025
Q1
$11.3M Buy
+25,886
New +$10.4M 0.17% 128

Other funds holding ELV

ASR Vermogensbeheer's ELV Position: Q2 2026 in Review

ASR Vermogensbeheer increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $1.24M and bringing the position to 29,139 shares worth $11.3M. The position accounts for 0.12% of the portfolio, ranked #177.

ASR Vermogensbeheer first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • ASR Vermogensbeheer held 29,139 shares of Elevance Health worth $11.3M as of Q2 2026.
  • ASR Vermogensbeheer bought 3,331 Elevance Health shares in Q2 2026, an estimated $1.24M.
  • Elevance Health made up 0.12% of ASR Vermogensbeheer's portfolio in Q2 2026, its #177 holding.
  • ASR Vermogensbeheer first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.